The Shape grading system: a classification for growth patterns of pituitary adenomas.
Grading
Outcome
Pituitary
Shape
Transsphenoidal
Tumor
Journal
Acta neurochirurgica
ISSN: 0942-0940
Titre abrégé: Acta Neurochir (Wien)
Pays: Austria
ID NLM: 0151000
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
received:
08
03
2021
accepted:
10
06
2021
pubmed:
6
7
2021
medline:
25
11
2021
entrez:
5
7
2021
Statut:
ppublish
Résumé
Long-term tumor control of pituitary adenomas may be achieved by gross total resection (GTR). Factors, which influence the extent of resection, are invasiveness, tumor size, and possibly tumor shape. Nevertheless, the latter factor has not been assessed so far and there is no classification for the different shapes. The aim of this study was to evaluate the impact of different tumor shapes on GTR rates and outcome according to our proposed "Shape grading system." In this retrospective single center study, the radiological outcome of nonfunctioning pituitary adenomas was assessed with respect to the following previously defined growth patterns: spherical (Shape I), oval (Shape II), dumbbell (Shape III), mushroom (Shape IV), and polylobulated (Shape V). A total of 191 patients were included (Shape I, n = 28 (15%); Shape II, n = 91 (48%); Shape III, n = 37 (19%); Shape IV, n = 12 (6%); Shape V, n = 23 (12%)). GTR was achieved in 101 patients (53%) with decreasing likelihood of GTR in higher shape grades (Shape I, n = 23 (82%); Shape II, n = 67 (74%); Shape III, n = 9 (24%); Shape IV, n = 2 (17%); Shape V, n = 0 (0%)). This correlated with larger tumor remnants, a higher risk of tumor recurrence/regrowth and therefore necessity of re-surgery and/or radiotherapy/radiosurgery. The "Shape grading system" may be used as a predictor of the outcome in nonfunctioning pituitary adenomas. The higher the "Shape grade," the higher the likelihood for lower GTR rates, larger tumor remnants, and need for further therapies.
Sections du résumé
BACKGROUND
Long-term tumor control of pituitary adenomas may be achieved by gross total resection (GTR). Factors, which influence the extent of resection, are invasiveness, tumor size, and possibly tumor shape. Nevertheless, the latter factor has not been assessed so far and there is no classification for the different shapes. The aim of this study was to evaluate the impact of different tumor shapes on GTR rates and outcome according to our proposed "Shape grading system."
METHODS
In this retrospective single center study, the radiological outcome of nonfunctioning pituitary adenomas was assessed with respect to the following previously defined growth patterns: spherical (Shape I), oval (Shape II), dumbbell (Shape III), mushroom (Shape IV), and polylobulated (Shape V).
RESULTS
A total of 191 patients were included (Shape I, n = 28 (15%); Shape II, n = 91 (48%); Shape III, n = 37 (19%); Shape IV, n = 12 (6%); Shape V, n = 23 (12%)). GTR was achieved in 101 patients (53%) with decreasing likelihood of GTR in higher shape grades (Shape I, n = 23 (82%); Shape II, n = 67 (74%); Shape III, n = 9 (24%); Shape IV, n = 2 (17%); Shape V, n = 0 (0%)). This correlated with larger tumor remnants, a higher risk of tumor recurrence/regrowth and therefore necessity of re-surgery and/or radiotherapy/radiosurgery.
CONCLUSION
The "Shape grading system" may be used as a predictor of the outcome in nonfunctioning pituitary adenomas. The higher the "Shape grade," the higher the likelihood for lower GTR rates, larger tumor remnants, and need for further therapies.
Identifiants
pubmed: 34223996
doi: 10.1007/s00701-021-04912-1
pii: 10.1007/s00701-021-04912-1
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3181-3189Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.
Références
Ben-Shlomo A, Cooper O (2018) Silent corticotroph adenomas. Pituitary 21:183–193
doi: 10.1007/s11102-018-0864-8
Brinjikji W, Lanzino G, Cloft HJ (2014) Cerebrovascular complications and utilization of endovascular techniques following transsphenoidal resection of pituitary adenomas: a study of the Nationwide Inpatient Sample 2001–2010. Pituitary 17:430–435
doi: 10.1007/s11102-013-0521-1
Chen L, White WL, Spetzler RF (2011) A prospective study of nonfunctioning pituitary adenomas: presentation, management and clinical outcome. J Neurooncol 102:129–138
doi: 10.1007/s11060-010-0302-x
Esposito D, Olsson DS, Ragnarson O (2019) Non-functioning pituitary adenomas: indications for surgery and post-surgical management. Pituitary 22:422–434
doi: 10.1007/s11102-019-00960-0
Hardy J, Wigser SM (1965) Trans-sphenoidal surgery of pituitary fossa tumors with televised radiofluoroscopic control. J Neurosurg 23:612–619
doi: 10.3171/jns.1965.23.6.0612
Honegger J, Ernemann U, Psaras T, Will B (2007) Objective criteria for successful transsphenoidal removal of suprasellar nonfunctioning pituitary adenomas. Acta Neurochir (Wien) 149:21–29
doi: 10.1007/s00701-006-1044-6
Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33:610–618
pubmed: 8232800
Lundin P, Pedersen F (1992) Volume of pituitary adenomas: assessment by MRI. J Comput Assist Tomogr 16:519–528
doi: 10.1097/00004728-199207000-00004
Malta M, Cardoso LO, Bastos FI, Magnanini MM, Silva CM (2010) STROBE initiative: guidelines on reporting observational studies. Rev Saude Publica 44:559–565
doi: 10.1590/S0034-89102010000300021
Micko ASG, Wöhrer A, Wolfsberger S (2015) Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification. J Neurosurg 122:803–811
doi: 10.3171/2014.12.JNS141083
Ramakrishnan VR, Suh JD, Lee JY, O’Malley BW, Grady MS, Palmer JN (2013) Sphenoid sinus anatomy and suprasellar extension of pituitary tumors. J Neurosurg 119:669–674
doi: 10.3171/2013.3.JNS122113
Shou XF, Li SQ, Wang YF, Zhao Y, Jia PF, Zhou LF (2005) Treatment of pituitary adenomas with transsphenoidal approach. Neurosurgery 56:249–256
doi: 10.1227/01.NEU.0000147976.06937.1D
Trouillas J, Roy P, Sturm N (2013) A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up. Acta Neuropathol 126:123–135
doi: 10.1007/s00401-013-1084-y